Shoukat Dedhar

Title: Shoukat Dedhar: Innovator in Cancer Research

Introduction

Shoukat Dedhar is a notable inventor based in Richmond, California. He has made significant contributions to the field of cancer research, focusing on innovative methods for cancer detection and treatment. Although he currently holds no patents, his work has the potential to impact cancer prognosis and therapy.

Latest Patents

Dedhar's latest patents include "Carbonic Anhydrase IX-Related Markers and Use Thereof." This patent provides methods for detecting cancer stem cells, which can be crucial for cancer prognosis, evaluating the risk of metastasis, identifying drug candidates, and determining treatment efficacy. Additionally, it includes kits for detecting cancer stem cells and methods for treating cancer using CAIX inhibitors. Another significant patent is "Novel Sulfonamide Compounds for Inhibition of Metastatic Tumor Growth." This patent discloses therapeutic sulfonamide compounds that selectively inhibit CAIX and CAXII, effectively inhibiting hypoxic tumor growth and suppressing metastases.

Career Highlights

Throughout his career, Dedhar has worked with esteemed organizations such as the British Columbia Cancer Agency and SignalChem Lifesciences Corporation. His experience in these institutions has allowed him to develop and refine his innovative approaches to cancer treatment.

Collaborations

Dedhar has collaborated with notable colleagues, including Paul C. McDonald and Frances E. Lock. These partnerships have contributed to the advancement of his research and the development of new therapeutic strategies.

Conclusion

Shoukat Dedhar is a dedicated inventor whose work in cancer research holds promise for improving cancer detection and treatment. His innovative approaches and collaborations highlight his commitment to advancing medical science.